TWST
Twist Bioscience Corporation · Healthcare · Medical - Diagnostics & Research
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +8 | 54.73M | $5.62B | +14 | −6 |
| Q1 2026 | 108 | +15 | 51.20M | $2.43B | +20 | −5 |
| Q4 2025 | 92 | -2 | 51.46M | $1.63B | +1 | −3 |
| Q3 2025 | 18 | 0 | 32.97M | $927.70M | +1 | −2 |
| Q2 2025 | 16 | -3 | 28.73M | $1.06B | — | −3 |
| Q1 2025 | 16 | +1 | 15.75M | $618.44M | +2 | −1 |
| Q4 2024 | 15 | 0 | 15.20M | $706.21M | — | — |
| Q3 2024 | 14 | +1 | 11.38M | $514.14M | +2 | −1 |
| Q2 2024 | 13 | — | 12.61M | $621.59M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.13M | — | $302.06M | 2.7% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 1.43M | — | $70.36M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 1.43M | — | $70.36M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 1.34M | — | $66.13M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 1.34M | — | $66.13M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 984.30K | — | $48.51M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 984.30K | — | $48.51M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 984.30K | — | $48.51M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 984.30K | — | $48.51M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 782.38K | — | $38.56M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 673.06K | — | $33.17M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 579.23K | — | $28.54M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 276.46K | — | $13.62M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 276.46K | — | $13.62M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (pasif) | 239.53K | — | $11.80M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 79.05K | — | $3.90M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 61.43K | — | $3.03M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 61.43K | — | $3.03M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 61.43K | — | $3.03M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 34.75K | — | $1.71M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 4.07K | — | $200,767 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 279 pemegang, 76.80M saham, $3.56B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 854 lbr · $120,220
Officer · 669 lbr · $93,035
Officer · 1.60K lbr · $222,227
Officer · 1.97K lbr · $273,265
Officer · 1.36K lbr · $189,130
Officer · 4.05K lbr · $562,661
Officer, Director · 6.64K lbr · $923,259
Officer · 14.21K lbr · $1.84M
Officer · 2.00K lbr · $245,162
Officer · 6.30K lbr · $761,860
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi